Search by Drug Name or NDC

    NDC 64764-0625-30 Nesina 6.25 mg/1 Details

    Nesina 6.25 mg/1

    Nesina is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is ALOGLIPTIN BENZOATE.

    Product Information

    NDC 64764-0625
    Product ID 64764-625_c5487e88-84e3-41df-ab12-fd2140cc6ef2
    Associated GPIs 27550010100310
    GCN Sequence Number 070525
    GCN Sequence Number Description alogliptin benzoate TABLET 6.25 MG ORAL
    HIC3 C4J
    HIC3 Description ANTIHYPERGLYCEMIC, DPP-4 INHIBITORS
    GCN 34086
    HICL Sequence Number 039968
    HICL Sequence Number Description ALOGLIPTIN BENZOATE
    Brand/Generic Brand
    Proprietary Name Nesina
    Proprietary Name Suffix n/a
    Non-Proprietary Name alogliptin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 6.25
    Active Ingredient Units mg/1
    Substance Name ALOGLIPTIN BENZOATE
    Labeler Name Takeda Pharmaceuticals America, Inc.
    Pharmaceutical Class Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022271
    Listing Certified Through 2024-12-31

    Package

    NDC 64764-0625-30 (64764062530)

    NDC Package Code 64764-625-30
    Billing NDC 64764062530
    Package 30 TABLET, FILM COATED in 1 BOTTLE (64764-625-30)
    Marketing Start Date 2013-01-25
    NDC Exclude Flag N
    Pricing Information N/A